Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia

Psychiatric Services - United States
doi 10.1176/appi.ps.201700398
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Psychiatric Association Publishing


Related search